Follow Us On Social Media

 
 
READ ARTICLE

Ocrevus Receives FDA Greenlight for Relapsing, Primary Progressive Forms of Multiple Sclerosis

The FDA has approved Ocrevus (ocrelizumab, Roche/Genentech) for the treatment of both relapsing and primary progressive forms of multiple sclerosis. Ocrelizumab is a humanized antibody that targets CD20 marker on B lymphocytes. It is the first drug approved in the US for the treatment of p…

READ ARTICLE

New Evidence Suggests Potential for Blood-Based Alzheimer’s Biomarker

READ ARTICLE

Review Identifies Antidepressants and AEDs Effective for Nerve Pain

READ ARTICLE

Novel Adjunct Agent Approved for Parkinson’s "Off" Periods

READ ARTICLE

Sunovion Submits NDA to Expand Aptiom Indication to Pediatric Patients

Contact Info

For advertising rates and opportunities:
Steve Farrell
Publisher
973-768-8681
sfarrell@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC